CryoCell Historical Income Statement
| CCEL Stock | USD 9.07 0.06 0.67% |
Historical analysis of CryoCell International income statement accounts such as Selling General Administrative of 11.2 M, Total Revenue of 18.4 M or Gross Profit of 27.7 M can show how well CryoCell International performed in making a profits. Evaluating CryoCell International income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of CryoCell International's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining CryoCell International latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CryoCell International is a good buy for the upcoming year.
CryoCell |
About CryoCell Income Statement Analysis
CryoCell International Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to CryoCell International shareholders. The income statement also shows CryoCell investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
CryoCell International Income Statement Chart
CryoCell International Income Statement is one of the three primary financial statements used for reporting CryoCell's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of CryoCell International revenue and expense. CryoCell International Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, CryoCell International's Non Recurring is quite stable compared to the past year. Add Fundamental
Gross Profit
Gross profit is a required income statement account that reflects total revenue of CryoCell International minus its cost of goods sold. It is profit before CryoCell International operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of CryoCell International. It is also known as CryoCell International overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from CryoCell International's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into CryoCell International current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.At this time, CryoCell International's Non Recurring is quite stable compared to the past year.
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 21.5M | 22.9M | 26.3M | 27.7M | Total Revenue | 30.3M | 31.3M | 36.0M | 18.4M |
CryoCell International income statement Correlations
Click cells to compare fundamentals
CryoCell International Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CryoCell International income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | (19.2K) | 1.7M | 2.2M | 1.7M | 2.0M | 2.1M | |
| Selling General Administrative | 14.3M | 14.6M | 15.6M | 17.1M | 19.7M | 11.2M | |
| Total Revenue | 31.1M | 28.9M | 30.3M | 31.3M | 36.0M | 18.4M | |
| Gross Profit | 21.5M | 19.9M | 21.5M | 22.9M | 26.3M | 27.7M | |
| Other Operating Expenses | 24.1M | 24.5M | 25.9M | 27.9M | 32.0M | 17.4M | |
| Operating Income | 7.7M | 4.0M | 4.0M | (12.3M) | (14.1M) | (13.4M) | |
| Ebit | 7.7M | 4.0M | 4.0M | 3.5M | 4.0M | 4.2M | |
| Ebitda | 7.6M | 5.7M | 6.3M | 5.2M | 6.0M | 6.3M | |
| Cost Of Revenue | 9.7M | 9.0M | 8.8M | 8.4M | 9.7M | 5.6M | |
| Total Operating Expenses | 14.5M | 15.5M | 17.1M | 19.4M | 22.3M | 12.0M | |
| Income Before Tax | 5.0M | 2.6M | 3.3M | (13.4M) | (15.4M) | (14.6M) | |
| Total Other Income Expense Net | (2.6M) | (1.4M) | (705.5K) | (15.6M) | (14.1M) | (13.4M) | |
| Net Income | 3.6M | 2.1M | 2.8M | (9.5M) | (10.9M) | (10.4M) | |
| Income Tax Expense | 1.4M | 527.7K | 547.5K | (3.8M) | (4.4M) | (4.2M) | |
| Research Development | 23.9K | 49.9K | 384.8K | 1.2M | 1.3M | 1.4M | |
| Interest Expense | 1.5M | 1.4M | 1.5M | 1.2M | 1.4M | 1.2M | |
| Net Income Applicable To Common Shares | 2.3M | 3.6M | 2.1M | 2.8M | 3.2M | 2.1M | |
| Net Income From Continuing Ops | 3.6M | 2.1M | 2.8M | (9.5M) | (8.6M) | (8.1M) | |
| Tax Provision | 1.4M | 527.7K | 547.5K | (3.8M) | (3.5M) | (3.3M) | |
| Net Interest Income | (1.5M) | (1.4M) | (1.5M) | (1.2M) | (1.1M) | (1.2M) | |
| Reconciled Depreciation | 636.0K | 1.3M | 1.8M | 1.7M | 2.0M | 1.0M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as CryoCell International using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.Note that the CryoCell International information on this page should be used as a complementary analysis to other CryoCell International's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for CryoCell Stock analysis
When running CryoCell International's price analysis, check to measure CryoCell International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CryoCell International is operating at the current time. Most of CryoCell International's value examination focuses on studying past and present price action to predict the probability of CryoCell International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CryoCell International's price. Additionally, you may evaluate how the addition of CryoCell International to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is CryoCell International's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.25) | Earnings Share (1.17) | Revenue Per Share 3.783 | Quarterly Revenue Growth 0.004 | Return On Assets (0.01) |
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.